Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use

Annually, 8,000 women in England with previously untreatable advanced breast cancer will have access to drugs shown to slow disease’s progression

Thousands of women with previously untreatable breast cancer will have access to two “breakthrough” drugs that have been approved for NHS use.

The drugs, called palbociclib and ribociclib, have been shown to slow the progression of advanced cancer by at least 10 months and can delay the need for chemotherapy, giving women the chance to live a normal life for longer. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved the drugs for widespread use in the health service in England for the first time.

Related: Cheap drug could cut 10% of UK breast cancer deaths, charity says

Related: New therapy offers hope against incurable form of breast cancer

Continue reading... November 16, 2017 at 11:31AM